Mather Group LLC. grew its stake in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 4.7% in the fourth quarter, HoldingsChannel.com reports. The firm owned 39,498 shares of the company’s stock after purchasing an additional 1,787 shares during the period. Mather Group LLC.’s holdings in AbbVie were worth $6,121,000 as of its most recent […]
Private Wealth Partners LLC cut its holdings in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 1.6% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 154,947 shares of the company’s stock after selling 2,440 shares during the quarter. AbbVie comprises 2.0% of Private Wealth Partners LLC’s portfolio, making the stock its 19th […]
AbbVie (NYSE:ABBV – Get Free Report) posted its quarterly earnings results on Friday. The company reported $2.31 earnings per share for the quarter, topping analysts’ consensus estimates of $2.26 by $0.05, Briefing.com reports. The business had revenue of $12.31 billion during the quarter, compared to analyst estimates of $11.93 billion. AbbVie had a net margin […]
AbbVie (NYSE:ABBV – Get Free Report) issued an update on its second quarter 2024 earnings guidance on Friday morning. The company provided earnings per share (EPS) guidance of 3.050-3.090 for the period, compared to the consensus estimate of 2.810. The company issued revenue guidance of $14.0 billion-$14.0 billion, compared to the consensus revenue estimate of […]
Bank of New Hampshire lessened its holdings in AbbVie Inc. (NYSE:ABBV – Free Report) by 27.3% during the fourth quarter, Holdings Channel.com reports. The firm owned 19,207 shares of the company’s stock after selling 7,211 shares during the quarter. Bank of New Hampshire’s holdings in AbbVie were worth $2,977,000 as of its most recent filing […]